Revere Pharmaceuticals Inc. — Form D/A
Revere Pharmaceuticals Inc. of ARLINGTON, MA, a company, filed a Form D amendment with the SEC on 2020-06-22. The offering totals $3.5M, of which $1.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-06-22
- Form: D/A
- Accession: 0001778959-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.6M
- Remaining: $1.9M
- Investors: 30
- Date of first sale: 2019-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342452
Issuer
- Name: Revere Pharmaceuticals Inc.
- CIK: 0001778959
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 36 ORVIS ROAD, ARLINGTON, MA, 02474
- Phone: 781-718-9033
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kollol Robert Pal | Director | Arlington, MA |
| Marc Robert Lippman | Director | Arlington, MA |
| Ian Robert Silverman | Director | Arlington, MA |
| Ian Robert Silverman | Executive Officer | Arlington, MA |
| Jedd Robert Levine | Director | Arlington, MA |
| Jedd Robert Levine | Executive Officer | Arlington, MA |
Other filings by this issuer (4)
More